Eisai
4523.T
#2204
Rank
S$10.86 B
Marketcap
S$38.51
Share price
1.56%
Change (1 day)
2.69%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.12. an increase over its 2024 EPS that were of S$1.26.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025S$1.4111.85%
2024S$1.26-32.63%
2023S$1.875.52%
2022S$1.77-74.01%
2021S$6.81-66.58%
2020S$20.3998.24%
2019S$10.2817.01%
2018S$8.7937.78%
2017S$6.38-27.62%
2016S$8.8135.33%
2015S$6.51-2.82%
2014S$6.70-27.66%
2013S$9.26-27.49%
2012S$12.78-12.67%
2011S$14.6388.08%
2010S$7.78-11.06%
2009S$8.75-390.15%
2008S-$3.01-127.78%
2007S$10.8511.78%
2006S$9.714.38%
2005S$9.307.4%
2004S$8.6643.03%
2003S$6.0625.09%
2002S$4.8452.67%
2001S$3.1769.76%
2000S$1.87